%PDF-1.4
%
30 0 obj
<>
endobj
27 0 obj
<>
endobj
83 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2003-04-09T16:37:10Z
2024-03-28T05:00:06-07:00
QuarkXPressª 4.11: AdobePS 8.6 (219)
2024-03-28T05:00:06-07:00
application/pdf
Heather
2002-554.may
uuid:00ab8b6d-1dd2-11b2-0a00-070a276d7200
uuid:00ab8b70-1dd2-11b2-0a00-b80000000000
endstream
endobj
16 0 obj
<>
endobj
17 0 obj
<>
endobj
31 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
4 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
7 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
97 0 obj
[101 0 R]
endobj
98 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.03 612 -792 re
W n
BT
/CS0 cs 0 0 0 1 scn
/GS1 gs
/T1_0 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 74.4 714.5293 Tm
[(JF)79.7 (. Survival, prognosis and causes of death in rheumatoid arthritis.)]TJ
0 -1.25 TD
(Arthritis Rheum 1986;29:706-14.)Tj
-1.675 -1.25 Td
[(4.)-875.1 (Mutru O, Laakso M, Isomaki H, Koota K. )17.7 (T)69.9 (en year mortality and)]TJ
1.675 -1.25 Td
(causes of death in patients with rheumatoid arthritis. BMJ)Tj
0 Tc 0 Tw T*
[(1985;290:1)36.9 (197-9.)]TJ
-0.00011 Tc 0.02499 Tw -1.675 -1.25 Td
[(5.)-875.1 (Hazenber)17.7 (g BPC, van Rijswijk MH. )17.7 (Where has secondary amyloid)]TJ
0 Tc 1.675 -1.25 Td
[(gone? )54.9 (Ann Rheum Dis 2000;59:577-9.)]TJ
-0.00011 Tc -1.675 -1.25 Td
[(6.)-875.1 (Myllykangas LR, )54.8 (Aho K, Kautianen H, Hakala M. )54.8 (Amyloidosis in a)]TJ
1.675 -1.25 Td
(nationwide series of 1666 subjects with rheumatoid arthritis who)Tj
T*
(died during 1989 in Finland. Rheumatology 1999;38:499-503.)Tj
-1.675 -1.25 Td
[(7.)-875.1 (Casanovas EG, Sanmarti R, Sole M, Canete JD, Gomez JM. )17.7 (The)]TJ
1.675 -1.25 Td
(clinical significance of amyloid fat deposits in rheumatoid arthritis.)Tj
T*
(Arthritis Rheum 2001;44:66-72.)Tj
-1.675 -1.25 Td
[(8.)-875.1 (Mansoury )17.7 (TME, Hazenber)17.7 (g BPC, Badawy SAE, )54.8 (Ahmed )54.8 (AH, Bijzet)]TJ
1.675 -1.25 Td
[(J, Limbur)17.7 (g PC, Rijswijk MH. Screening for amyloid in)]TJ
T*
(subcutaneous fat tissue of Egyptian patients with rheumatoid)Tj
T*
[(arthritis: clinical and laboratory characteristics. )54.8 (Ann Rheum Dis)]TJ
0 Tc 0 Tw T*
(2002;61:42-7.)Tj
-0.00011 Tc 0.02499 Tw -1.675 -1.25 Td
[(9.)-875.1 (Kobayashi H, )17.7 (T)69.9 (ada S, Fuchigami )17.7 (T)74 (, et al. Secondary amyloidosis in)]TJ
1.675 -1.25 Td
(patients with rheumatoid arthritis: diagnostic and prognostic value)Tj
T*
[(of gastroduodenal biopsy)64.8 (. Br J Rheumatol 1996;35:44-9.)]TJ
-2.175 -1.25 Td
[(10.)-875.1 (Barile L, )54.8 (Ariza R, Muci H, et al. )17.7 (T)35 (ru-cut needle biopsy of)]TJ
2.175 -1.25 Td
(subcutaneous fat in the diagnosis of secondary amyloidosis in)Tj
T*
[(rheumatoid arthritis. )54.8 (Arch Med Res 1993;24:189-92.)]TJ
-2.1381 -1.25 Td
[(1)36.8 (1)-0.1 (.)-875.1 (W)79.9 (estermark P)110.7 (, Stenkvist B. )54.8 (A)-220.1 (new method for the diagnosis of)]TJ
2.1381 -1.25 Td
[(systemic amyloidosis. )54.8 (Arch intern Med 1973;132: 522-3.)]TJ
-2.175 -1.25 Td
[(12.)-875.1 (Guy CD, Jones CK. )54.8 (Abdominal fat pad aspiration biopsy for tissue)]TJ
2.175 -1.25 Td
(confirmation of systemic amyloidosis. Diagn Cytopathol)Tj
0 Tc 0 Tw T*
(2001;24:181-5.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(13.)-875.1 (Duston MA, Skinner M, Shirahama )17.7 (T)74 (,)-0.1 ( Cohen )54.8 (AS. Diagnosis of)]TJ
2.175 -1.25 Td
(amyloidosis by abdominal fat aspiration: analysis of 4 years)Tj
T*
[(experience. )54.9 (Am J Med 1987;82:412-4.)]TJ
30.825 38.75 Td
[(14.)-875.1 (Duston MA, Skinner M, Meenan RF)79.7 (, Cohen )54.8 (AS. Sensitivity)64.8 (,)]TJ
2.175 -1.25 Td
(specificity and predictive value of abdominal fat aspiration for the)Tj
T*
[(diagnosis of amyloidosis. )54.8 (Arthritis Rheum 1989;32:82-5.)]TJ
-2.175 -1.25 Td
[(15.)-875.1 (Blumenfeld )17.7 (W)91.9 (, Hildebrandt RH. Fine-needle aspiration of)]TJ
2.175 -1.25 Td
[(abdominal fat for the diagnosis of amyloidosis. )54.8 (Acta Cytol)]TJ
0 Tc 0 Tw T*
(1993;37:170-4.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(16.)-875.1 (Masouye I. Diagnostic screening of systemic amyloidosis by)]TJ
2.175 -1.25 Td
[(abdominal fat aspiration: an analysis of 100 cases. )54.8 (Am J)]TJ
T*
(Dermatopathol 1997;19:41-5.)Tj
-2.175 -1.25 Td
[(17.)-875.1 (Arnett FC, Edworthy SM, Bloch DA, et al. )17.7 (The )54.8 (American)]TJ
2.175 -1.25 Td
[(Rheumatism )54.8 (Association 1987 revised criteria for the classification)]TJ
T*
[(of rheumatoid arthritis. )54.8 (Arthritis Rheum 1988;31:315-24.)]TJ
-2.175 -1.25 Td
[(18.)-875.1 (T)35 (iitinen S, Kaarela K, Helin H, Kautiainen H, Isomaki H.)]TJ
2.175 -1.25 Td
(Amyloidosis- incidence and early risk factors in patients with)Tj
T*
(rheumatoid arthritis. Scand J Rheumatol. 1993;22:158-61.)Tj
-2.175 -1.25 Td
[(19.)-875.1 (Gratacos J, Orellana C, Sanmarti R, et al. Secondary amyloidosis in)]TJ
2.175 -1.25 Td
(ankylosing spondylitis: a systematic survey of 137 patients using)Tj
T*
(abdominal fat aspiration. J Rheumatol 1997;24:912-5.)Tj
-2.175 -1.25 Td
[(20.)-875.1 (T)69.9 (ahara K, Nishiya K, )36.8 (Y)99.8 (oshida )17.7 (T)74 (, et al. )54.8 (A)-220.1 (case of secondary systemic)]TJ
2.175 -1.25 Td
(amyloidosis associated with rheumatoid arthritis after 3-year)Tj
T*
[(disease duration. R)39.7 (yumachi 1999;39:27-32.)]TJ
-2.175 -1.25 Td
[(21.)-875.1 (T)69.9 (animoto K, Nakamura M, Okada K, Nagasawa K, Niho )36.8 (Y)128.9 (.)-0.1 ( )54.8 (A)]TJ
2.175 -1.25 Td
(young woman with rheumatoid arthritis who rapidly developed)Tj
T*
(secondary amyloidosis. Nihon Rinsho Meneki Gakkai Kaishi)Tj
0 Tc 0 Tw T*
(1995;18:83-9.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(22.)-875.1 (Hazenber)17.7 (g BPC, Limbur)17.7 (g PC, Bijzet J, van Rijswijk MH. )54.8 (A)]TJ
2.175 -1.25 Td
[(quantitative method for detecting deposits of amyloid )54.8 (A)-220.1 (protein in)]TJ
T*
[(aspirated tissue of patients with arthritis. )54.8 (Ann Rheum Dis)]TJ
0 Tc 0 Tw T*
(1999;58:96-102.)Tj
ET
0 0 0 0 scn
420 777 137 -27 re
f*
408 770 150 -25 re
f*
/CS0 CS 0 0 0 1 SCN
54 54 m
558 54 l
S
BT
0 0 0 1 scn
/T1_1 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 54.5 35.9844 Tm
[(W)91.9 (akhlu, et al: )17.7 (Amyloidosis in RA)]TJ
0 Tc 0 Tw 61.4375 -0.0313 Td
(951)Tj
ET
0 0 0 0 scn
/GS0 gs
109.22 59.09 396.48 -10.84 re
f*
0.5 w
109.22 59.09 396.48 -10.84 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 0 0 rg
/GS2 gs
/T1_2 8 Tf
117.48 51 Td
(Personal, non-commercial use only. The Journal of Rheumatology Copyrig\
ht \251 2003. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_3 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
44 0 obj
<>
endobj
33 0 obj
<>
endobj
74 0 obj
<>
endobj
88 0 obj
<>
endobj
34 0 obj
<>
endobj
69 0 obj
<>stream
HT{PSgM( hn V|vQyhQR!J$!1[P,V[ueԞ~lwvwfGf|sw~ߜ߇c&6n۶}e@ȗ8m"03L3txp2⒅)ó6#o_yyfe]F8eVQ\,K#D\n7v[vr/c#D88Lʏtim%|qcZ h8,/EhoAH*ntXl
$p R&%供ppl0K51l-1V`0l-H F`$`װq|^4b51fTm\MX"ۍ] Lmw8&W3x3z]3sf͚?k9HYwxh)s ds"<4W!Qb1JOIɪWk`eFp׃3p;O.UY!<=xJq$ϰR)'wնeh*:7-Ffh86-5]usIP]8\ZdE]^[ݖ#TD'zED(L$+SԜlΞKOcX;%^$D鵆x=%
٠͎GN6$tnW\<{@XƝMo|ik:Y
)3dKqWJU^838'̀fa]vvAE
꘣i٩